Email this article 
New opportunities in the treatment of cutaneous lymphoid hyperplasia
- Authors: Olisova O.Y.1, Anpilogova E.M.1
-
Affiliations:
- I.M. Sechenov First Moscow State Medical University (Sechenov University)
- Issue: Vol 23, No 1 (2020)
- Pages: 17-22
- Section: CLINICAL PICTURE, DIAGNOSIS, AND THERAPY OF DERMATOSES
- URL: https://rjsvd.com/1560-9588/article/view/41722
- DOI: https://doi.org/10.17816/dv2020117-22
- Cite item
Open Access
Access granted
Abstract
Here, we present the results of our research regarding the efficacy of photodynamic therapy (PDT) in cutaneous lymphoid hyperplasia (CLH). We observed five patients with CLH. The diagnoses were confirmed both clinically and through laboratory testing. The response to treatment was defined by the index of the modified assessment of the severity of the skin lesions scale (mSWAT). PDT (665 ± 10 nm) with topical photosensitizer application was performed once a week. The PDT course consisted of 4 ± 2 sessions. After the therapy, complete remission was achieved in four patients (80%; mSWAT 95–100%) and partial remission in one patient (20%; mSWAT 63%). Thus, PDT proved to be an effective and safe method for treating CLH.
Full Text
About the authors
O. Yu. Olisova
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Author for correspondence.
Email: olisovaolga@mail.ru
ORCID iD: 0000-0003-2482-1754
MD, PhD, DSc, Head of Department of Dermatology and Venereology
Russian Federation, Moscow, 119991E. M. Anpilogova
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Email: olisovaolga@mail.ru
ORCID iD: 0000-0001-9478-5838
Department of Dermatology and Venerology
Russian Federation, Moscow, 119991References
- Olisova O.Yu., Potekaev N.S. Cutaneous pseudolymphomas (etiology, clinical picture, diagnosis and treatment). Manual for physicians. Moscow: Medical Center of the Presidential Executive Office of Russian Federation; 2002. (in Russian)
- Nihal M., Mikkola D., Horvath N., Gilliam A., Stevens S., Spiro T., et al. Cutaneous lymphoid hyperplasia: a lymphoproliferative continuum with lymphomatous potential. Hum. Pathol. 2003; 34(6):617-22. doi: 10.1016/s0046-8177(03)00075-3.
- Tomar S., Stoll H., Grassi M., Cheney R. Treatment of cutaneous pseudolymphoma with interferon alfa-2b. J. Am. Acad. Dermatol. 2009; 60(1):172-4. doi: 10.1016/j.jaad.2008.07.052.
- Stoll D. Treatment of cutaneous pseudolymphoma with hydroxychloroquine. J. Am. Acad. Dermatol. 1983; 8(5):696-9.
- El-Dars L., Statham B., Blackford S., Williams N. Lymphocytoma cutis treated with topical tacrolimus. Clin. Exp. Dermatol. 2005; 30(3):305-7.
- Martin S., Duvic M. Treatment of cutaneous lymphoid hyperplasia with the monoclonal anti-CD20 antibody rituximab. Clin. Lymphoma Myeloma Leuk. 2011; 11(3):286-8. doi: 10.1016/j.clml.2011.03.017.
- Dionyssopoulos A., Mandekou-Lefaki I., Delli F., Kourtis D., Nikolis A., Dionyssopoulou E. T- and B-cutaneous pseudolymphomas treated by surgical excision and immediate reconstruction. Dermatol. Surg. 2006; 32(12):1526-9.
- Taylor R., Fortney J., Pollack R., Metcalf J., Jenrette J. Radiation therapy for B-cell cutaneous lymphoid hyperplasia. Jpn. J. Radiol. 2010; 28(5):385-7. doi: 10.1007/s11604-010-0439-8
- Oliveira E., Badiale G., Moraes M. Lymphocytoma cutis: Case report. An Bras. Dermatol. 2013; 88(6, Suppl. 1):128-31. doi: 10.1590/abd1806-4841.20132320.
- Mikasa K., Watanabe D., Kondo C., Tamada Y., Matsumoto Y. Topical 5-aminolevulinic acid-based photodynamic therapy for the treatment of a patient with cutaneous pseudolymphoma. J. Am. Acad. Dermatol. 2005; 53(5):911-2.
- Takeda H., Kaneko T., Harada K., Matsuzaki Y., Nakano H., Hanada K. Successful treatment of lymphadenosis benigna cutis with topical photodynamic therapy with delta-aminolevulinic acid. Dermatology. 2005; 211(3):264-6.
- O’Neill J., Fien S., Zeitouni N. ALA-PDT for the treatment of cutaneous pseudolymphoma: a case report. J. Drugs. Dermatol. 2010; 9(6):688-9.
Supplementary files
